Catalyst Wire Dossier Catalyst Wire Dossier

Sifalimumab

sifalimumab · MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sifalimumab, covering 2016-07-11 to 2016-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus [Phase 2]

See pricing